Cargando…
Fatal lactic acidosis in hepatitis B virus-associated decompensated cirrhosis treated with tenofovir: A case report
RATIONALE: Recently tenofovir disoproxil fumarate (TDF) has been widely used as a first-line therapy for chronic hepatitis B (CHB) infection. Although TDF demonstrates successful viral suppression, the possibility of renal failure and lactic acidosis has been proposed with TDF administration, especi...
Autores principales: | Jung, Tae Yang, Jun, Dae Won, Lee, Kang Nyeong, Lee, Hang Lak, Lee, Oh Young, Yoon, Byung Chul, Choi, Ho Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484195/ https://www.ncbi.nlm.nih.gov/pubmed/28640087 http://dx.doi.org/10.1097/MD.0000000000007133 |
Ejemplares similares
-
Estimating of hepatic fat amount using MRI proton density fat fraction in a real practice setting
por: Lee, Hyeyoung, et al.
Publicado: (2017) -
Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis
por: Lee, Soon Kyu, et al.
Publicado: (2017) -
Sofosbuvir and ribavirin in acute hepatitis C–infected patient with decompensated cirrhosis
por: Liu, Hui, et al.
Publicado: (2016) -
Fatal Tenofovir-Associateacd Lactic Acidosis: A Case Report
por: Hashim, Hasriza, et al.
Publicado: (2015) -
Risk factors associated with hypophosphatemia in chronic Hepatitis B patients treated with tenofovir disoproxil fumarate
por: Lee, Dohyeong, et al.
Publicado: (2019)